SBC vs VRSK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SBC · SBC Medical Group$5.04 ▲ 0.40%
VRSK · Verisk Analytics$204.59 ▼ 3.25%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SBC +47.4%
- VRSK -2.9%
Head to head
| Metric | SBC | VRSK |
|---|---|---|
| Price | $5.04 | $204.59 |
| Change today | ▲ 0.40% | ▼ 3.25% |
| Market cap | $518.35M | $26.25B |
| Return, 3 months | +63.6% | +13.2% |
| Return, year to date | +16.9% | -7.8% |
| Return, 1 year | +60.0% | -3.7% |
| P/E (TTM) | 10.5 | 31.0 |
| P/B | 2.0 | -23.6 |
| P/E percentile vs own 5y | 85th | 27th |
| Dividend yield | – | 0.95% |
| Revenue growth (YoY, latest qtr) | +13.4% | +5.3% |
| Net profit growth (YoY) | +357.5% | -2.8% |
| Gross margin | 71.9% | 70.2% |
| Operating margin | 37.3% | 43.9% |
| Net margin | 28.0% | 27.7% |
| Return on equity | 19.3% | – |
| Analyst target vs. price | +68.7% | +17.4% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 46 | 62 |
| 30-day volatility | 51.5% | 40.3% |
| Max drawdown, 1 year | -41.7% | -32.6% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VRSK is the largest of the group by market value.
- SBC has returned the most over the past year.
- SBC carries the lowest trailing P/E.
- SBC is growing revenue fastest.
- SBC keeps the most profit per dollar of sales.
- VRSK has been the calmest stock over the last 30 days.